| 2004 |
REX1 is a ring-stage protein that localizes to Maurer's clefts in P. falciparum-infected erythrocytes. It contains predicted coiled-coil regions and a region with similarity to a domain in vesicle-tethering proteins, and persists in Maurer's clefts throughout erythrocyte infection. |
Immunofluorescence microscopy, sequence analysis, transcriptional profiling |
Molecular and biochemical parasitology |
Medium |
15481109
|
| 2008 |
REX1 export to Maurer's clefts occurs via a two-phase PEXEL-independent mechanism: a single hydrophobic stretch plus 10 additional amino acids mediates export across the parasitophorous vacuole membrane as a soluble protein, while a predicted coiled-coil sequence is required for final localization at the Maurer's clefts. |
Transgenic parasites expressing GFP-REX1 chimeras with truncations; biochemical fractionation |
Traffic (Copenhagen, Denmark) |
High |
18489703
|
| 2008 |
REX1 is required for normal Maurer's cleft architecture: REX1-GFP preferentially associates with edges of Maurer's clefts, vesicle-like structures, and stalk-like tethering extensions. Truncation or deletion of REX1 causes stacking of Maurer's cleft cisternae. Complementation of D10 parasites (which lack rex1) with full-length REX1-GFP restores the unstacked (3D7-type) Maurer's cleft phenotype. |
Transgenic parasite lines expressing REX1 truncations or deletion; electron microscopy; complementation assay in D10 parasites |
Molecular microbiology |
High |
18573183
|
| 2011 |
REX1 is required for assembly of the P. falciparum virulence complex at the host erythrocyte surface. Truncation of the REX1 C-terminal domain compromises Maurer's cleft architecture and PfEMP1-mediated cytoadherence but permits some PfEMP1 trafficking to the RBC surface. Deletion of the REX1 coiled-coil region ablates PfEMP1 surface display, trapping PfEMP1 at Maurer's clefts. Complementation with REX1 partly restores PfEMP1-mediated CD36 binding. Complete REX1 deletion is associated with loss of KAHRP and defective KAHRP-GFP trafficking. |
Targeted mutagenesis (truncation and deletion) of REX1; immunofluorescence; cytoadherence assay to CD36; KAHRP-GFP trafficking assay; complementation |
Molecular microbiology |
High |
21696460
|
| 2015 |
A repeat sequence domain of REX1 controls Maurer's cleft architecture and virulence protein trafficking. Inducible knockdown of REX1 causes stacking of Maurer's cleft cisternae. Loss of the repeat sequence domain results in formation of giant Maurer's cleft stacks that retain tether-like structures and the ability to dock onto the RBC membrane skeleton, but show deficient PfEMP1 export to the RBC surface and markedly reduced CD36 binding. REX1 is predicted to form a largely α-helical structure with a repetitive charge pattern in the repeat sequence domain. |
Inducible knockdown; transgenic parasites with REX1 domain deletions; immunofluorescence; electron microscopy; CD36 binding assay; structural prediction |
Molecular microbiology |
High |
26304012
|
| 2016 |
REX1 is ubiquitylated in P. falciparum-infected red blood cells, with ubiquitylation reaching a maximum level at the trophozoite stage. |
Tandem Ubiquitin-Binding Entities (TUBEs) pulldown coupled to mass spectrometry across ring, trophozoite, and schizont stages |
Journal of proteomics |
Medium |
26972027
|
| 2009 |
Synthetic peptides from conserved regions of REX1 bind specifically and saturably to red blood cell proteins. Three REX1-derived high-activity binding peptides (HABPs) were identified; their binding was sensitive to enzymatic treatment of RBCs, indicating dependence on specific RBC surface receptors. |
Solid-phase peptide synthesis; RBC binding assays with saturation and enzyme-treatment controls; circular dichroism |
Vaccine |
Low |
19755146
|
| 2014 |
REX1 was identified as a potential interaction partner of the Maurer's cleft membrane protein SEMP1 by co-immunoprecipitation, with co-localization at Maurer's clefts confirmed. |
Co-immunoprecipitation (Co-IP); immunofluorescence co-localization |
PloS one |
Low |
25062022
|
| 2021 |
PfMC-2TM tightly co-localizes with REX1 at Maurer's clefts from as early as 4 hours post-invasion, establishing REX1 as a marker of nascent Maurer's clefts at the earliest stages of erythrocyte infection. |
Immunofluorescence co-localization with anti-REX1 antibodies in synchronized P. falciparum 3D7 cultures |
Pathogens (Basel, Switzerland) |
Low |
33916455
|